<SEC-DOCUMENT>0001193125-25-236083.txt : 20251009
<SEC-HEADER>0001193125-25-236083.hdr.sgml : 20251009
<ACCEPTANCE-DATETIME>20251009172717
ACCESSION NUMBER:		0001193125-25-236083
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20251009
FILED AS OF DATE:		20251009
DATE AS OF CHANGE:		20251009

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMMUTEP Ltd
		CENTRAL INDEX KEY:			0001506184
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35428
		FILM NUMBER:		251385919

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE
		STREET 2:		264 GEORGE STREET
		CITY:			SYDNEY,
		STATE:			C3
		ZIP:			NSW 2000
		BUSINESS PHONE:		612 8315 7003

	MAIL ADDRESS:	
		STREET 1:		LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE
		STREET 2:		264 GEORGE STREET
		CITY:			SYDNEY,
		STATE:			C3
		ZIP:			NSW 2000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Prima BioMed Ltd
		DATE OF NAME CHANGE:	20101119
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d62582d6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML><HEAD>
<TITLE>6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
<DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM&nbsp;6-K </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE&nbsp;13a-16 OR 15d-16 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Date as October 09, 2025 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number&nbsp;001-35428 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>IMMUTEP LIMITED </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
Name as Specified in its Charter) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N/A </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of
Registrant&#8217;s Name) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Level&nbsp;32, Australia Square </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>264 George Street, Sydney </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NSW 2000, Australia </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover of Form&nbsp;20-F or Form&nbsp;40-F. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form 20-F&#8194;&#9746;&#8195;&#8195;&#8195;Form 40-F&#8194;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form&nbsp;6-K in paper as permitted by Regulation&nbsp;S-T Rule&nbsp;101(b)(1):&#8194;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form&nbsp;6-K in paper as permitted by Regulation&nbsp;S-T Rule&nbsp;101(b)(7):&#8194;&#9744; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the
Commission pursuant to Rule&nbsp;12g3-2(b) under the Securities Exchange Act of 1934. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&#8194;&#9744;&#8195;&#8195;&#8195;No&#8194;&#9746; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If &#8220;Yes&#8221; is marked, indicated below the file number assigned to the registrant in connection with Rule&nbsp;12g3-2(b): Not applicable. </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;
</DIV><DIV STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="94%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Exhibit</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Description&nbsp;of&nbsp;Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">99.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><A HREF="d62582dex991.htm">Immutep Announces Update for TACTI-004 (KEYNOTE-F91) Phase III Trial in First Line Non-Small Cell Lung Cancer</A></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: October 09, 2025 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">IMMUTEP LIMITED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Marc Voigt</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Marc Voigt</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d62582dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g62582snap5.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Immutep Announces Update for TACTI-004 (KEYNOTE-F91) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Phase III Trial in First Line <FONT STYLE="white-space:nowrap">Non-Small</FONT> Cell Lung Cancer </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Global Phase III trial has enrolled and randomised over 170 patients, reaching an important milestone as this
is above the amount needed to conduct the futility analysis</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Over 100 clinical sites across 24 countries now activated and open for recruitment</I> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Futility analysis remains on track for completion in the first quarter of CY2026</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SYDNEY, AUSTRALIA &#8211; October 09, 2025 &#8211;</B> Immutep Limited (ASX: IMM; NASDAQ: IMMP) (&#8220;Immutep&#8221; or &#8220;the Company&#8221;), a
late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces a patient enrolment update for the TACTI-004 (KEYNOTE-F91) Phase III trial evaluating eftilagimod alfa (efti) in combination with MSD&#8217;s
(Merck&nbsp;&amp; Co., Inc., Rahway, NJ, USA) anti-PD-1 therapy KEYTRUDA<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (pembrolizumab) and chemotherapy as first line treatment for advanced or metastatic
<FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer (1L NSCLC). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This registrational Phase III trial has enrolled and randomised over 170
patients, reaching an important milestone as this is above the amount necessary to conduct the futility analysis. Additionally, the number of activated clinical trial sites continues to expand at a strong pace and there are now over 100 active
clinical sites across 24 countries globally. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The futility analysis will be assessed by an independent data monitoring committee (IDMC) based on the data
of a predefined number of patients with sufficient <FONT STYLE="white-space:nowrap">follow-up</FONT> (minimum 12 weeks) and predefined criteria for efficacy. The trial remains on track for the IDMC to conduct the futility analysis in the first
quarter of CY2026. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Immutep Chief Executive Officer, Marc Voigt, said,</B> &#8220;We are very pleased with the pace of enrolment in our pivotal Phase
III trial that we believe has the potential to change the treatment landscape in <FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer, one of the largest indications in oncology with over two million diagnoses annually worldwide. The
trial remains on track for key milestones ahead including futility analysis in early 2026.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Immutep CMO, Stephan Winckels, M.D., Ph.D.,</B>
<B>added</B>, &#8220;Our engagement with the principal investigators and physicians in the lung cancer community at medical conferences throughout the year, including WCLC 2025 last month, has consistently resulted in constructive feedback. Notably,
their favourable assessments of the trial design and of efti as an innovative immunotherapy&#8212;capable of safely increasing response rates and improving efficacy in <FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer patients
regardless of <FONT STYLE="white-space:nowrap">PD-L1</FONT> expression&#8212;provide a strong basis for ongoing positive enrolment trends.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
TACTI-004 trial follows positive efficacy and safety results from two previous studies, TACTI-002 and <FONT STYLE="white-space:nowrap">INSIGHT-003,</FONT> which tested efti with KEYTRUDA in 1L NSCLC. With in total over 165 patients enrolled, both
trials demonstrate that efti enhances anti-PD-1 therapy regardless of <FONT STYLE="white-space:nowrap">PD-L1</FONT> expression levels. The novel combination of these two immunotherapies has led to high response rates and strong progression-free
survival (PFS). Both trials show these responses and PFS translate into significantly improved overall survival, addressing a high unmet need for these patients. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g62582snap6.jpg" ALT="LOGO">
 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lung cancer is the leading cause of death among all cancer types and the incidence is set to increase to
approximately 3&nbsp;million cases worldwide by 2030.<SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;NSCLC is the most common type of lung cancer representing <FONT STYLE="white-space:nowrap">~80-85%</FONT> of all diagnoses.<SUP
STYLE="font-size:75%; vertical-align:top">2</SUP>&nbsp;The condition is often diagnosed at a late stage, and less than 30% of patients are alive five years after diagnosis.<SUP STYLE="font-size:75%; vertical-align:top">3,4</SUP>&nbsp;There remains a
high unmet need for additional treatment options for people living with NSCLC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KEYTRUDA<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> is a
registered trademark of Merck Sharp&nbsp;&amp; Dohme LLC, a subsidiary of Merck&nbsp;&amp; Co., Inc., Rahway, NJ, USA. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About TACTI-004 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TACTI-004 (<B>T</B>wo<B>&nbsp;ACT</B>ive<B>&nbsp;I</B>mmunotherapies) is a randomised, double-blind, controlled Phase III study evaluating eftilagimod alfa
(efti), a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class</FONT></FONT> MHC Class&nbsp;II agonist, in combination with MSD&#8217;s (Merck&nbsp;&amp; Co., Inc., Rahway, NJ, USA) anti-PD-1 therapy KEYTRUDA<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (pembrolizumab) and chemotherapy as first line therapy for patients with advanced or metastatic <FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer with no EGFR, ALK or ROS1
genomic tumour aberrations. The global trial will enrol approximately 756 patients regardless of <FONT STYLE="white-space:nowrap">PD-L1</FONT> expression and with <FONT STYLE="white-space:nowrap">non-squamous</FONT> or squamous tumours at over 150
clinical sites in over 25 countries. Patients will be randomised 1:1 to receive either efti in combination with pembrolizumab and chemotherapy in the treatment arm or pembrolizumab in combination with chemotherapy and placebo in the control arm. The
study&#8217;s dual primary endpoints are progression-free survival and overall survival. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Eftilagimod Alfa (Efti) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Efti is a novel immunotherapy that directly activates antigen-presenting cells or APCs (e.g. dendritic cells, monocytes) via the MHC Class&nbsp;II pathway to
fight cancer. As an MHC Class&nbsp;II agonist, its activation of APCs engages the adaptive and innate immune system to initiate a broad anti-cancer immune response. This includes priming and activating cytotoxic T cells as well as generating
important <FONT STYLE="white-space:nowrap">co-stimulatory</FONT> signals&nbsp;&amp; cytokines that further boost the immune system&#8217;s ability to combat cancer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Efti is under evaluation for a variety of solid tumours including <FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer (NSCLC) in a pivotal
Phase III trial called TACTI-004 (KEYNOTE-F91), as well as head and neck squamous cell carcinoma (HNSCC), soft tissue sarcoma, and breast cancer. Its favourable safety profile enables various combinations like with anti-PD-[L]1 immunotherapy,
radiotherapy, and/or chemotherapy. Efti has received Fast Track designation in first line HNSCC and in first line NSCLC from the United States Food and Drug Administration (FDA). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Immutep </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immutep is a late-stage biotechnology
company developing novel immunotherapies for cancer and autoimmune disease<I>.</I> The Company is a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation <FONT STYLE="white-space:nowrap">Gene-3</FONT><B> </B><FONT
STYLE="white-space:nowrap">(LAG-3),</FONT> and its diversified product portfolio harnesses <FONT STYLE="white-space:nowrap">LAG-3&#8217;s</FONT> ability to stimulate or suppress the immune response. Immutep is dedicated to leveraging its expertise
to bring innovative treatment options to patients in need and to maximise value for shareholders. For more information, please visit www.immutep.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g62582snap6.jpg" ALT="LOGO">
 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>1. International Agency for Research on Cancer &#8211; World Health Organization. Rates of trachea,
bronchus and lung cancer. </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>2. Zappa C&nbsp;&amp; Mousa <FONT STYLE="white-space:nowrap">Non-small</FONT> cell lung cancer: current treatment and
future advances, Transl Lung Cancer Res. 2016 Jun; 5(3): 288&#8211;300. </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>3. Polanco D et al. Prognostic value of symptoms at lung cancer diagnosis:
a three-year observational study. J Thorac Dis 2021;13:1485&#8211;1494. </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>4. National Cancer Institute Surveillance, Epidemiology, and End Results
(SEER) - https://seer.cancer.gov/statfacts/html/lungb.html </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Australian Investors/Media: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Eleanor Pearson, Sodali&nbsp;&amp; Co. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+61 2 9066 4071;
eleanor.pearson@sodali.com </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>U.S. Investors/Media: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chris Basta, VP, Investor Relations and Corporate Communications </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 (631) 318 4000; chris.basta@immutep.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This announcement
was authorised for release by the CEO of Immutep Limited. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g62582snap6.jpg" ALT="LOGO">
 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g62582snap5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g62582snap5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !D U$# 1$  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^[B@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M2E5PF*I/EK8:JXV7-!M2C*R52E.G5249I'IM8'O!0 4 % !0 4 % !0 4 %
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MH8* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MG.)EE.;>S>,=.53"XFG!4GB/9)RK4JU.-J:K1@I58RI0IP<(5$X1E%.?(_\
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MJ,]:BE'FE#^IFOBC]E$  &   .@ P!^ H 6@ H * "@ H * "@ H * "@ H
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MW_U)F?CM_P '&W_)S/P)_P"R%/\ ^I_XKKZ#A/\ W+$_]A3_ /3-(^#\5O\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M]I-M0@W&+E"E&G"3C%N+:3/LJO//?"@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MCET^R\5(+W6_"/PAT?2;6W\8VR1^'KK[/9>+OB7K^C_#^SA NX;!9KO7%O\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MUNQ@\!Z)\.M TK2;;QAXJBT/4M/^$.J:AKGPO_X2C21J_P!C\477@77-5O\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g62582snap6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g62582snap6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !5 TP# 1$  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_B@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M9?H17DGZZ% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M_C= !_:MA_SW_P#(4W_QN@ _M6P_Y[_^0IO_ (W0 ?VK8?\ /?\ \A3?_&Z
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M?_R%-_\ &Z #^U;#_GO_ .0IO_C= !_:MA_SW_\ (4W_ ,;H /[5L/\ GO\
M^0IO_C= !_:MA_SW_P#(4W_QN@ _M6P_Y[_^0IO_ (W0 ?VK8?\ /?\ \A3?
M_&Z #^U;#_GO_P"0IO\ XW0 ?VK8?\]__(4W_P ;H /[5L/^>_\ Y"F_^-T
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MC@JV)BI>2KX>BU?JD?T-?VK8?\]__(4W_P ;KY(_L(/[5L/^>_\ Y"F_^-T
M']JV'_/?_P A3?\ QN@ _M6P_P">_P#Y"F_^-T <?0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M5K3C3IPYIN,(\TY)<TY1BKWDTDV<%\(OBY\//CO\.O#/Q8^%/B#_ (2KX?\
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MGQ%HNA:IH?A?Q!H.K:X_AH0:_8>)]#M=<46-KHOB/6M4M)]&%TFFZQ'KEAI
M;44D.C/K&FA-1?U\PP%7+<7C\#B:E+ZUE^:9CE=>E3=27-++ZD*+QE*;IQIR
MP>+JNK#"J4X8Q/#5I8K!X6,L/*OX>4YI1SG+\LS3"4<1'!9KDV69SAJM=48.
M$,SA6JQP%:G"O4J1QV$H0P]?%.$:F!Y,=AH87'8JO3QM+!]L2 "20  223@
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MK&AB)PKRAAJ\J?T97">N% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M[ N<*<\MQ#PE*M3Q,Y/"UL;"5:-/ZPZ]15/E^%.'L1@*/AK',\!1A++JG'V
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MPI\0M%\:?LY7G@*#PU\2O,B\+7^LQW7QVL/B!9O,+=);RSMO 5]>6<=U;B2
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M#V5QJYA0J8/+ZN+P-XU\F_6@< #TKY9ZMON?H"5DDNB2^X*!A0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
A % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
